Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Perspective Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 49 | 52 | +3 |
| Shares | 36.5M | 36.6M | +76.7K (+0.2%) |
| Value | $9.99M | $14.7M | +$4.71M (+47.1%) |
New holders (11)
Institutions that held Perspective Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ghost Tree Capital, LLC | 1,600,000 | $643.2K | 0.37% |
| Portland Investment Counsel Inc. | 142,550 | $57.0K | 0.02% |
| Mariner, LLC | 47,778 | $19.2K | 0.00% |
| ADAR1 Capital Management, LLC | 42,200 | $17.0K | 0.01% |
| Cerity Partners LLC | 40,000 | $16.1K | 0.00% |
| Sphera Funds Management Ltd. | 25,671 | $10.3K | 0.00% |
| AE Wealth Management LLC | 10,850 | $6.79K | 0.00% |
| Advisory Services Network, LLC | 1,000 | $402 | 0.00% |
| Bank of America Corp | 167 | $67 | 0.00% |
| HighPoint Advisor Group LLC | 15,700 | – | – |
| RIA Advisory Group LLC | 7,560 | – | – |
Sold out (8)
Institutions that held Perspective Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Two Sigma Securities, LLC | 76,565 | $21.0K |
| Cetera Investment Advisers | 65,000 | $17.8K |
| LPL Financial LLC | 26,658 | $7.30K |
| Susquehanna International Group, LLP | 19,338 | $5.29K |
| KilterHowling LLC | 14,625 | $4.00K |
| Goldman Sachs Group Inc | 13,373 | $3.66K |
| Virtu Financial LLC | 12,729 | $3.00K |
| Chilton Capital Management LLC | 500 | $137 |